Chemotherapy and targeted therapy are reshaping the acute myeloid leukemia treatment market. Chemotherapy remains the dominant treatment approach, while targeted therapy is emerging as a fast-growing segment due to advancements in personalized medicine and the growing understanding of AML's molecular mechanisms. The AML treatment market is projected to grow from USD 3.438 billion in 2025 to...